- Home
- SRFM vs PDSB Comparison
SRFM vs PDSB Comparison
Compare SRFM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- PDSB
- Stock Information
- Founded
- SRFM 2011
- PDSB 2005
- Country
- SRFM United States
- PDSB United States
- Employees
- SRFM N/A
- PDSB N/A
- Industry
- SRFM Transportation Services
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- SRFM Consumer Discretionary
- PDSB Health Care
- Exchange
- SRFM Nasdaq
- PDSB Nasdaq
- Market Cap
- SRFM 58.2M
- PDSB 58.7M
- IPO Year
- SRFM 2023
- PDSB N/A
- Fundamental
- Price
- SRFM $4.15
- PDSB $1.66
- Analyst Decision
- SRFM Hold
- PDSB Strong Buy
- Analyst Count
- SRFM 2
- PDSB 3
- Target Price
- SRFM $3.40
- PDSB $14.00
- AVG Volume (30 Days)
- SRFM 399.9K
- PDSB 235.3K
- Earning Date
- SRFM 11-14-2024
- PDSB 11-14-2024
- Dividend Yield
- SRFM N/A
- PDSB N/A
- EPS Growth
- SRFM N/A
- PDSB N/A
- EPS
- SRFM N/A
- PDSB N/A
- Revenue
- SRFM $118,212,000.00
- PDSB N/A
- Revenue This Year
- SRFM $102.41
- PDSB N/A
- Revenue Next Year
- SRFM $47.46
- PDSB N/A
- P/E Ratio
- SRFM N/A
- PDSB N/A
- Revenue Growth
- SRFM 198.78
- PDSB N/A
- 52 Week Low
- SRFM $0.90
- PDSB $1.30
- 52 Week High
- SRFM $9.38
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- SRFM 49.30
- PDSB 50.61
- Support Level
- SRFM $3.45
- PDSB $1.41
- Resistance Level
- SRFM $5.18
- PDSB $1.73
- Average True Range (ATR)
- SRFM 0.59
- PDSB 0.13
- MACD
- SRFM -0.04
- PDSB 0.04
- Stochastic Oscillator
- SRFM 40.46
- PDSB 83.64
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.